Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get FeederDidn't you hear? The next space race is on! Not interested in space? How about the latest cancer treatments, or how the next generation electric car engines will work. Science baby!
Suggest an editTable of Contents for New England Journal of Medicine. List of articles from both the latest and ahead of print issues.
Inverse covers the latest news on science, innovation, entertainment, technology and culture by asking: What could happen next?
Latest articles published in Chemical Reviews.
Nature Biotechnology is a monthly journal publishing new concepts in biological technology of relevance to bioengineering, medicine, energy, agriculture, food and the environment. It has a magazine covering the commercial, political, ethical, legal and societal aspects of this research.
Xatakaciencia es un weblog colectivo dedicado a la divulgación científica, la ecología y el cambio climático
Nature Genetics is the primary research journal for the genetics community. With a reputation for quality global coverage, Nature Genetics delivers the latest research across the field, including human genetics and genomics, genomics in plant and animal breeding, epigenetics, cancer and genetic technology. With News and Views, Analysis, Perspectives, Letters, Articles and Technical Reports, Nature Genetics is consistently the most frequently cited primary research journal in the field of Genetics and Heredity.
Serving the Technologist since 1998. News, reviews, and analysis.
RSS Feed for Frontiers in Neuroscience | New and Recent Articles
Physical Review LettersEditors' Suggestions (by suggesting a few manuscripts each week, we hope to promote reading across fields of physics)
Tracking retractions as a window into the scientific process
Read our latest news on regulatory decisions and activities, including product safety and enforcement actions.
Your one stop shop for everything photo and video
Original research articles published in Nature Medicine range from basic findings that have clear implications for disease pathogenesis and therapy to the earliest phases of human investigation. Aiming to keep Ph.D. and M.D. readers informed of a wide range of biomedical research findings, the journal publishes the latest advances in cancer biology, vascular biology, neuroscience, inflammatory disease, infectious disease and metabolic disorders, among other fields. Reviews, Perspectives and other commissioned content clarify and give context to these biomedical research advances, and the News section reports on the latest developments in drug research and development.
Top stories in the U.S. and world news, politics, health, science, business, music, arts and culture. Nonprofit journalism with a mission. This is NPR.
Nature Reviews Drug Discovery integrates academia and industry, providing broad, expert coverage of the whole drug discovery and development arena – from disease mechanisms, novel therapeutic approaches and chemistry to clinical trials and regulatory affairs. All reviews are carefully commissioned, written by leaders in the field and subject to rigorous peer-review so that readers receive independent, high-quality and authoritative articles in each issue. Reviews are complemented by news stories that investigate the key issues in drug discovery, timely summaries of significant published papers, market analysis, and updates on the latest advances in fast-moving areas such as new technologies, drug approvals and patent law. Information is presented at several levels that can be tailored to users’ individual needs. Non-specialists will benefit from the glossary and highlighted references, and experts will appreciate the insight provided by top names in their field. Nature Revi
All of the latest articles published at eLife, including in-progress POA (publish-on-accept) articles.
Travel Notices to inform travelers and clinicians about current health issues related to specific destinations
Latest articles published by American Chemical Society.